A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.

A computer model developed by researchers from Japan and Seattle's Allen Institute could lead to new methods for studying ...

Understanding how bone marrow produces blood–and how this whole process can fail–is critical to fighting blood cancers and ...

A new study provides a powerful way to study infections in environments that closely mimic human organs. The strategy, tested ...

Down syndrome is caused by an error in cell division during development. Individuals receive three copies of chromosome 21 instead of the typical two copies, resulting in duplicates of the genes ...

Tumors trigger T-cell exhaustion through a TSP-1–CD47 signaling pathway. Blocking it can restore immune strength and improve cancer treatment.

Nucleome is backed by a world-class syndicate of investors: M Ventures, the venture capital arm of Merck KGaA; Johnson and Johnson Innovation - JJDC, Inc. ("JJDC"); Pfizer Ventures; British Business ...

Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.

For the first time, scientists have grown functional, brain-like tissue without using any animal-derived materials or added ...

Researchers found that competition for nutrients plays a significant role in which bacteria thrive, diminish or disappear due ...

Stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells can force tumors to self-destruct.